The Latest Cardiac and Vascular News
FRAMINGHAM, Mass.–(BUSINESS WIRE)–Boston Heart Diagnostics, one of the leading disease management laboratories in the United States, is pleased to announce the company’s newly-appointed scientific advisory board. Boston Heart Diagnostics’ 2018 Scientific Advisory Board is comprised of recognized experts in their respective medical fields. Boston Heart Diagnostics’ Scientific Advisory Board includes: […]
OAKLAND, Calif.–(BUSINESS WIRE)–LUMEDX Corporation, a provider of wholly integrated cardiovascular data intelligence and imaging solutions, announced today that it is working with Duke Health to implement a comprehensive cardiovascular information system (CVIS) for Duke’s non-invasive cardiac labs. The implementation marks the third phase of a larger Duke-LUMEDX CVIS project, which […]
RESEARCH TRIANGLE PARK, N.C. & TORONTO–(BUSINESS WIRE)–Analytics 4 Life, a digital health company dedicated to improving existing diagnostic pathways, today announced that clinical data will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2018 scientific symposium. Dr. Thomas Stuckey, a primary investigator on the Company’s Coronary Artery Disease Learning and […]
LAVAL, Quebec, Sept. 18, 2018 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, today provided a clinical and market update. Jan D’Alvise, president […]
WESTMINSTER, Colo., Sept. 18, 2018 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today announced that it has submitted a Special Protocol Assessment (SPA) request to the U.S. Food and Drug Administration (FDA). The request is part of the […]
BEIJING, Sept. 18, 2018 /PRNewswire/ — Huami Corporation (“Huami” or the “Company”) (NYSE: HMI), a biometric and activity data-driven company with significant expertise in smart wearable technology, today announced the launch of the new generation health band, Amazfit Health Band 1S, which delivers new features and benefits powered by AI technologies and brings advanced […]
MARLBOROUGH, Mass., Sept. 17, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE :BSX ) today announced key data that will be presented at the 30th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, in San Diego, on September 21 – September 25. Data from the head-to-head IMPERIAL trial evaluating the ELUVIA™ […]
BE’ER SHEVA, Israel, and HARTFORD, Conn., Sept. 18, 2018 /PRNewswire/ — DiA Imaging Analysis Ltd. (DiA), a provider of artificial intelligence (AI)-powered ultrasound analysis tools, announced today that its LVivo EF cardiac decision-support software is now available for purchase for GE’s new Vscan Extend™ handheld, pocket-sized ultrasound. This collaboration is an outgrowth of work between DiA […]
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–AtaCor Medical, Inc. (www.atacor.com) announced today that it has completed a $8.8M Series A financing. Co-led by Boston-based Broadview Ventures and Israel-based aMoon Ventures, the financing also includes participation from a corporate partner. The investment will support the continued development of AtaCor’s revolutionary extravascular substernal cardiac pacing […]
RALEIGH, N.C., Sept. 18, 2018 /PRNewswire/ — Contego Medical announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the first filter-based Integrated Embolic Protection (IEP) device, the Paladin® Carotid PTA Balloon System. Contego Medical is developing and commercializing a suite of next-generation devices that address unmet needs in […]
